Umer Shoukat, MD
Internal Medicine · Wyomissing, PANPI 1316394158
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $423 of the $523 with a category attached, or 80.9%. 13 manufacturers reported payments, led by GSK at 28.4% of the total. 2025 is the largest year on record at $337, more than ten times the $13 reported in 2019.
Across 22 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$149
- Harmony Biosciences LLC$100
- Olympus Corporation Of The Americas$60
- Axsome Therapeutics, Inc.$47
- Regeneron Healthcare Solutions, Inc.$27
- Verona Pharma, Inc.$22
- plus $119 from 7 others
What the payments were for
- Food & beverage$42381%
- Education$10019%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $149 |
| Harmony Biosciences LLC | 1 | $100 |
| Olympus Corporation Of The Americas | 1 | $60 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Verona Pharma, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Merck | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
$523 in reported general payments places this provider in the 65th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Wyomissing
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.